ProShares Ultra Nasdaq Biotechnology
BIB
#2840
ETF rank
C$0.14 B
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ US
Market
C$163.73
Share price
-2.18%
Change (1 day)
53.64%
Change (1 year)

Expense ratio and fees for ProShares Ultra Nasdaq Biotechnology (BIB)

Expense Ratio

Expense Ratio as of November 2026: 0.95%

Gross Expense Ratio

Gross Expense Ratio as of November 2026: 1.17%

Net Expense Ratio

Net Expense Ratio as of November 2026: 0.95%